Literature DB >> 3091700

Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis.

V Stenszky, L Kozma, G Szegedi, N R Farid.   

Abstract

We have studied the distribution of IgG heavy chain markers (Gm) among 90 Hungarian patients with systemic lupus erythematosus (SLE) (55 of whom were also typed for HLA). This study confirms previously described increases in HLA-B8 and DR3 in this condition. No difference in the distribution of Gm phenotypes was found between patients and 168 controls from the same geographical area. HLA-B8/Gm homozygous individuals were, however, at greater risk for SLE (relative risk = 5.13) compared to B8 + Gm heterozygotes or B8- individuals, irrespective of Gm phenotype. When patients with renal manifestation (n = 40) were compared to those without, the Gm phenotype 3; 5, 13 was found to be significantly increased (chi 2 = 10.36, P less than 0.0001, relative risk (RR) = 4.69). HLA and Gm increased additively the risk for renal manifestations in that for those patients who were both Gm3;5,13+ and HLA-B8+, PR was 110, while it was 21.2 for Gm3;5, 13-/B8+, 7.9 for Gm3;5, 13+/B8- and 1.0 for Gm3;5, 13-/B8- patients. The study suggests that combined HLA and Gm typing can be used to identify SLE patients at high risk for manifesting renal abnormalities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091700     DOI: 10.1111/j.1744-313x.1986.tb01078.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  5 in total

1.  Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus.

Authors:  E B Lee; Y J Lee; D H Shin; Y M Choi; M H Park; J P Pandey; Y W Song
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

Review 2.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

3.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

4.  Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

Authors:  K Hartung; R Coldewey; E Röther; K Pirner; C Specker; D Schendel; W Stangel; S Stannat-Kiessling; G G de Lange
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

5.  The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms.

Authors:  M B Frank; K Itoh; A Fujisaku; P Pontarotti; M G Mattei; B R Neas
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.